electroCore, Inc. Announces Exclusive Distribution Agreement with East Agency For Qatar
ROCKAWAY, NJ, April 20, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced it has...
Month: April 2021
SCYNEXIS to Present Two Ibrexafungerp (Brexafemmeᵀᴹ) Posters at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting
JERSEY CITY, N.J., April 20, 2021 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to...
Shape Therapeutics Welcomes Patrick Bigot as its Chief Business Officer
SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene...
Ovid Therapeutics Announces Appointment of Professor Robert S. Langer, Sc.D., as Chair of its Scientific Advisory Board
NEW YORK, April 20, 2021 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that...
Coherus Announces Closing of Sale of Common Stock to Immuno-Oncology Partner Junshi Biosciences
Coherus received $50 million from sale of 2,491,998 shares at $20.06 per shareREDWOOD CITY, Calif., April 20, 2021 (GLOBE NEWSWIRE)...
Neuronetics to Report First Quarter 2021 Financial and Operating Results and Host Conference Call
MALVERN, Pa., April 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...
Jushi Holdings Inc. to Acquire Licensed Cultivator in Ohio
BOCA RATON, Fla., April 20, 2021 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF),...
GCAC Launches Uniswap Marketing Token
Adds Ether Cryptocurrency as Alternative Asset to Balance SheetVANCOUVER, British Columbia, April 20, 2021 (GLOBE NEWSWIRE) -- Global Cannabis Applications...
Surgery Partners, Inc. Announces Term Loan Refinancing and Conversion of Preferred Stock; Provides Preliminary First Quarter 2021 Financial Performance Update
Refinancing $119 million of incremental term loans raised in April 2020Provided notice to BCPE Seminole Holdings LP (“Bain Capital”) of...
Kaleido Biosciences Announces Collaboration with Robert Jenq, M.D., to Explore Potential of its Microbiome Metabolic Therapies (MMT™) in Preventing Febrile Neutropenia
LEXINGTON, Mass., April 20, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a small...
Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 5th Annual Genetic Medicines Manufacturing Summit
CAMBRIDGE, Mass., April 20, 2021 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing...
Evaxion Biotech Presents Paper on Potential of Deep Data on Immune Complex Stability to Optimize Cancer Immunotherapy
COPENHAGEN, Denmark, April 20, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (Nasdaq: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology...
Avicanna Announces Initial Listings and Sales for Evidence-Based RHO Phyto™ Products in Canada’s Adult Use Channels Including Ontario, Manitoba, Saskatchewan, and New Brunswick
Avicanna Inc. RHO Phyto Products Expanding from the successful nation-wide launch in medical-only channels through Medical Cannabis by Shoppers Drug...
Abeona Therapeutics Announces Presentation on New Preclinical Data Supporting the Potential of Cre-Mediated Dual AAV Vector Technology to Enable Delivery of Large Genes Targeted for Treatment of Stargardt Disease at ARVO 2021 Annual Meeting
NEW YORK and CLEVELAND, April 20, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene...
Repligen to Report First Quarter 2021 Financial Results
Webcast and Conference Call to Be Held Tuesday, May 4, 2021 at 8:30 a.m. EDTWALTHAM, Mass., April 20, 2021 (GLOBE...
Skylight Health Group Announces Fourth Quarter and Full-Year 2020 Results
Full-Year Revenues $13.1 million; Fourth Quarter Revenues rose to $3.2 million; Full Year 2021 Revenue Guidance $40 million; Acquired Six Primary Care Practices...
THC Therapeutics Has Completed the dHydronator® Consumer Model Design with photos
dHydronator® lineup. A lineup of the various potential trims options or colors for the finalized consumer model design of the...
Vertex Pharmaceuticals and CRISPR Therapeutics Amend Collaboration for Development, Manufacturing and Commercialization of CTX001™ in Sickle Cell Disease and Beta Thalassemia
- Under terms of amended agreement, Vertex to lead worldwide development, manufacturing and commercialization of CTX001- - Revised agreement provides...
PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial Evaluating Ketamine in the Treatment of Parkinson’s Disease
TORONTO, April 20, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE: PHRM) (OTCQB: PHRRF), a specialty...
KidneyIntelX Demonstrates Performance and Informs Treatment Decisions in Multinational CANagliflozin CardioVAScular Assessment Study (CANVAS)
Data from 1,325 CANVAS Participants with Baseline DKD Scored with KidneyIntelX Presented at International Society of Nephrology World Congress of...